As part of the research study, participants will engage in small group counseling sessions designed to address the concerns of women smokers who want to quit. There are a total of 18 sessions over the next year in Oakland. Participants will also take either Zyban, which has been FDA-approved for smoking cessation, or a placebo. To be eligible for the study, women must be between the ages of 18 and 65, in good health and not pregnant or planning on becoming pregnant during the next year. New sessions will start in January.
All calls are confidential.